
Lv Aifeng
Lv Aifeng is the director of the National and Local Joint Engineering Research Center for Long-acting Peptide Biopharmaceuticals, known for leading his team at Hansoh Pharmaceutical in the shift from generic to innovative drug development, focusing on breakthroughs that address unmet medical needs globally.
Power8,701
Reach871,418
Country presence
Recent news mentions
Lv Aifeng, the director of the National Local Joint Engineering Research Center for Long-acting Peptide Biopharmaceuticals, discusses the shift to innovative drug development.
高质量发展故事汇丨因地制宜 让新质生产力落地生根--经济·科技--人民网People's Daily·
China· 2026-07-30




